SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 153 filers reported holding SCICLONE PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $14,211,000 | -76.6% | 1,386,447 | -70.1% | 0.01% | -78.8% |
| Q2 2016 | $60,608,000 | +26.0% | 4,640,749 | +6.1% | 0.03% | +26.9% |
| Q1 2016 | $48,108,000 | +17.4% | 4,373,460 | -1.8% | 0.03% | +23.8% |
| Q4 2015 | $40,982,000 | +32.6% | 4,454,560 | 0.0% | 0.02% | +40.0% |
| Q3 2015 | $30,915,000 | -26.4% | 4,454,560 | +4.2% | 0.02% | -21.1% |
| Q2 2015 | $41,987,000 | +13.8% | 4,275,660 | +2.7% | 0.02% | +11.8% |
| Q1 2015 | $36,898,000 | +9.3% | 4,164,560 | +8.0% | 0.02% | +13.3% |
| Q4 2014 | $33,769,000 | +14.6% | 3,854,960 | -9.9% | 0.02% | +15.4% |
| Q3 2014 | $29,477,000 | +19.6% | 4,278,260 | -8.7% | 0.01% | +18.2% |
| Q2 2014 | $24,646,000 | +47.7% | 4,685,542 | +27.8% | 0.01% | +37.5% |
| Q1 2014 | $16,681,000 | -5.9% | 3,666,260 | +4.2% | 0.01% | -11.1% |
| Q4 2013 | $17,735,000 | +1.9% | 3,518,760 | +2.5% | 0.01% | 0.0% |
| Q3 2013 | $17,411,000 | -5.6% | 3,434,160 | -7.6% | 0.01% | -18.2% |
| Q2 2013 | $18,442,000 | – | 3,718,160 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athos Capital Ltd | 410,389 | $4,596,000 | 3.46% |
| GLG Partners LP | 2,586,437 | $28,968,000 | 1.54% |
| Nine Chapters Capital Management LLC | 32,300 | $362,000 | 0.80% |
| FNY Partners Fund LP | 335,900 | $3,762,000 | 0.64% |
| MENTA CAPITAL LLC | 373,523 | $4,183,000 | 0.61% |
| Yakira Capital Management, Inc. | 85,500 | $958,000 | 0.32% |
| Sapphire Star Partners LP | 18,724 | $209,000 | 0.27% |
| GAM Holding AG | 541,025 | $6,059,000 | 0.26% |
| Bowling Portfolio Management LLC | 127,873 | $1,432,000 | 0.22% |
| Kassirer Asset Management Corp | 15,000 | $168,000 | 0.16% |